Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse

Experimental Eye Research

Volumn 89, Issue 5, 2009, Pages 735-740

  Rex, Tonia S ^a   Wong, Ying ^b   Kodali, Kishore ^a   Merry, Shayla ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b CHRISTIAN BROTHERS UNIVERSITY   (United States)

Author keywords

dose dependent; erythropoietin; glycosylation; neuroprotection; photoreceptors; rds mouse

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PERINATAL PERIOD; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA DEGENERATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; GLYCOSYLATION; GREEN FLUORESCENT PROTEINS; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INJECTIONS; INTERMEDIATE FILAMENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PHOTORECEPTOR CELLS, VERTEBRATE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINAL DEGENERATION; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 70349445409     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.06.017     Document Type: Article

References (30)

1. Banks W., Jumbe N., Farrell C., Niehoff M., and Heatherington A. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. European Journal of Pharmacology 505 (2004) 93-101
2. Buhrer C., Felderhoff-Mueser U., and Wellmann S. Erythropoietin and ischemic conditioning - why two good things may be bad. Acta Paediatrica 96 (2007) 787-789
3. Cao W., Wen R., Li F., LaVail M., and Steinberg R. Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina. Experimental Eye Research 65 (1997) 241-248
4. Chang G., Hao Y., and Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 11 (1993) 595-605
5. Connell G., Bascom R., Molday L., Reid D., McInnes R., and Molday R. Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse. Proceedings of the National Academy of Sciences of the United States of America 88 (1991) 723-726
6. Delorme E., Lorenzini T., Giffin J., Martin F., Jacobsen F., Boone T., and Elliott S. Role of glycosylation on the secretion and biological activity of erythropoietin. Biochemistry 31 (1992) 9871-9876
7. Dordal M., Wang F., and Goldwasser E. The role of carbohydrate in erythropoietin action. Endocrinology 116 (1984) 2293-2299
8. Dube S., Fisher J., and Powell J. Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. The Journal of Biological Chemistry 263 (1988) 17516-17521
9. Elliott S., Egrie J., Browne J., Lorenzini T., Busse L., Rogers N., and Ponting I. Control of rHuEPO biological activity: the role of carbohydrate. Experimental Hematology 32 (2004) 1146-1155
10. Gassmann M., Heinicke K., Soliz J., and Ogunshola O. Non-erythroid functions of erythropoietin. Advances in Experimental Medicine and Biology 543 (2003) 323-330
11. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M., and Reme C. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nature Medicine 8 (2002) 718-724
12. Grimm C., Wenzel A., Stanescu D., Samardzija M., Hotop S., Groszer M., Naash M., Gassmann M., and Reme C. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. The Journal of Neuroscience 24 (2004) 5651-5658
13. Kilic U., Kilic E., Soliz J., Bassetti C., Gassmann M., and Hermann D. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. The FASEB Journal 19 (2005) 249-251
14. King C., Rodger J., Bartlett C., Esmaili T., Dunlop S., and Beazley L. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Experimental Neurology 205 (2007) 48-55
15. Kretz A., Happold C., Marticke J., and Isenmann S. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Molecular and Cellular Neuroscience 29 (2005) 569-579
16. van Nie R., Ivanyi D., and Demant P. A new H-2-linked mutation, rds, causing retinal degeneration in the mouse. Tissue Antigens 12 (1978) 106-108
17. Ranchon Cole I., Bonhomme B., and Doly M. Pre-treatment of adult rats with high doses of erythropoietin induces caspase-9 but prevents light-induced retinal injury. Experimental Eye Research 85 (2007) 782-789
18. Remtulla S., and Hallet P. A schematic eye for the mouse, and comparisons with the rat. Vision Research 25 (1985) 21-31
19. RetNet. Available from: (1996-2009). http://www.sph.uth.tmc.edu/retnet/
20. Rex T., Allocca M., Domenici L., Surace E., Maguire A., Lyubarsky A., Cellerino A., Bennett J., and Auricchio A. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Molecular Therapy 10 (2004) 855-861
21. Sakanaka M., Wen T.-C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 4635-4640
22. Sanyal S., De Ruiter A., and Hawkins R. Development and degeneration of retina in rds mutant mice: light microscopy. Journal of Comparative Neurology 194 (1980) 193-207
23. Statler P., McPherson R., Bauer L., Kellert B., and Juul S. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatric Research 61 (2007) 671-675
24. Steuer H., Jaworski A., Elger B., Kaussmann M., Keldenich J., Schneider H., Stoll D., and Schlosshauer B. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Investigative Ophthalmology and Visual Science 46 (2005) 1047-1053
25. Toledo J., Sánchez O., Seguí R., García G., Montañez M., Zamora P., Rodríguez M., and Cremata J. High expression level of recombinant human erythropoietin in the milk of non-transgenic goats. Journal of Biotechnology 123 (2006) 225-235
26. Travis G., Brennan M., Danielson P., Kozak C., and Sutcliffe J. Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature 338 (1989) 70-73
27. Weishaupt J., Rohde G., Polking E., Siren A.-L., Ehrenreich H., and Bahr M. Effect of erythropoietin on axotomy-induced apoptosis in rat retinal ganglion cells. Investigative Ophthalmology and Visual Science 45 (2004) 1514-1522
28. Xenocostas A., Cheung W., Farrell F., Zakszewski C., Kelley M., Lutynski A., Crump M., Lipton J., Kiss T., Lau C., and Messner H. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. European Journal of Pharmacology 61 (2005) 189-195
29. Zhang J., Wu Y., Jin Y., Ji F., Sinclair S., Luo Y., Xu G., Lu L., Dai W., Yanoff M., Li W., and Xu G. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Investigative Ophthalmology and Visual Science 49 (2008) 732-742
30. Zhong L., Bradley J., Schubert W., Ahmed E., Adamis A., Shima D., Robinson G., and Ng Y. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Investigative Ophthalmology and Visual Science 48 (2007) 1212-1218